P10636 |
TAU_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 |
TAU_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10636 |
TAU_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 |
TAU_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
P10636 |
TAU_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P10636 |
TAU_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 |
TAU_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P11473 |
VDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P11473 |
VDR_HUMAN |
Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 |
VDR_HUMAN |
Hyper-parathyroidism [ICD-11: 5A51] |
P11473 |
VDR_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
P11473 |
VDR_HUMAN |
Mineral deficiency [ICD-11: 5B5K] |
P11473 |
VDR_HUMAN |
Psoriasis [ICD-11: EA90] |
P11473 |
VDR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 |
VDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P11473 |
VDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 |
VDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P11473 |
VDR_HUMAN |
Prostate disease [ICD-11: GA91] |
P11473 |
VDR_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P11473 |
VDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 |
VDR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 |
VDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P22303 |
ACES_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P22303 |
ACES_HUMAN |
Glaucoma [ICD-11: 9C61] |
P22303 |
ACES_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P22303 |
ACES_HUMAN |
Oesophageal/gastroduodenal disorder [ICD-11: DD90] |
P22303 |
ACES_HUMAN |
Pediculosis [ICD-11: 1G00] |
P22303 |
ACES_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P22303 |
ACES_HUMAN |
Parasitic worm infestation [ICD-11: 1F90] |
P22303 |
ACES_HUMAN |
Dementia [ICD-11: 6D80-6D8Z] |
P22303 |
ACES_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P22303 |
ACES_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P22303 |
ACES_HUMAN |
Substance abuse [ICD-11: 6C40] |
P22303 |
ACES_HUMAN |
Lips/oral mucosa miscellaneous disorder [ICD-11: DA02] |
P22303 |
ACES_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P22303 |
ACES_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
P22303 |
ACES_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P22303 |
ACES_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P22303 |
ACES_HUMAN |
Glaucoma [ICD-11: 9C61] |
P22303 |
ACES_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P22303 |
ACES_HUMAN |
Oesophageal/gastroduodenal disorder [ICD-11: DD90] |
P22303 |
ACES_HUMAN |
Pediculosis [ICD-11: 1G00] |
P22303 |
ACES_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P22303 |
ACES_HUMAN |
Parasitic worm infestation [ICD-11: 1F90] |
P22303 |
ACES_HUMAN |
Dementia [ICD-11: 6D80-6D8Z] |
P22303 |
ACES_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P22303 |
ACES_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P22303 |
ACES_HUMAN |
Substance abuse [ICD-11: 6C40] |
P22303 |
ACES_HUMAN |
Lips/oral mucosa miscellaneous disorder [ICD-11: DA02] |
P22303 |
ACES_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P22303 |
ACES_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
P22303 |
ACES_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P23141 |
EST1_HUMAN |
Peroxisomal disease [ICD-11: 5C57] |
P23141 |
EST1_HUMAN |
Synthesis disorder [ICD-11: 5C52-5C59] |
P23141 |
EST1_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P23141 |
EST1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P23141 |
EST1_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
P23141 |
EST1_HUMAN |
Chronic arterial occlusive disease [ICD-11: BD4Z] |
O95398 |
RPGF3_HUMAN |
Epidermal dysplasias [ICD-11: EK90] |
P53350 |
PLK1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 |
PLK1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 |
PLK1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P53350 |
PLK1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 |
PLK1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P53350 |
PLK1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P53350 |
PLK1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08183 |
MDR1_HUMAN |
Lung cancer [ICD-11: 2C25] |
P08183 |
MDR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08183 |
MDR1_HUMAN |
Bacterial infection [ICD-11: 1A00-1C4Z] |
P08183 |
MDR1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P08183 |
MDR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P08183 |
MDR1_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
O94782 |
UBP1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q13148 |
TADBP_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 |
TADBP_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q13526 |
PIN1_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q13526 |
PIN1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
Q15910 |
EZH2_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q15910 |
EZH2_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
Q15910 |
EZH2_HUMAN |
Follicular lymphoma [ICD-11: 2A80] |
Q15910 |
EZH2_HUMAN |
Peritoneal cancer [ICD-11: 2C51] |
Q15910 |
EZH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q15910 |
EZH2_HUMAN |
Synovial sarcoma [ICD-11: 2B5A] |
Q15910 |
EZH2_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
Q15910 |
EZH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q15910 |
EZH2_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
Q15910 |
EZH2_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
Q15910 |
EZH2_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
Q15910 |
EZH2_HUMAN |
Ureteral cancer [ICD-11: 2C92] |
Q15910 |
EZH2_HUMAN |
B-cell lymphoma [ICD-11: 2A86] |
Q15910 |
EZH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
Q15910 |
EZH2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q15910 |
EZH2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 |
EHMT2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 |
EHMT2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 |
EHMT2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O14746 |
TERT_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
O14746 |
TERT_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
O14746 |
TERT_HUMAN |
Liver cancer [ICD-11: 2C12] |
O14746 |
TERT_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O14746 |
TERT_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
O14746 |
TERT_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
O14746 |
TERT_HUMAN |
Lung cancer [ICD-11: 2C25] |
O14746 |
TERT_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
O14746 |
TERT_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
O14746 |
TERT_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
O14746 |
TERT_HUMAN |
Thrombocytosis [ICD-11: 3B63] |
O14746 |
TERT_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O14746 |
TERT_HUMAN |
Melanoma [ICD-11: 2C30] |
O14746 |
TERT_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
O14746 |
TERT_HUMAN |
Glaucoma [ICD-11: 9C61] |
O14746 |
TERT_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
O14746 |
TERT_HUMAN |
Liver cancer [ICD-11: 2C12] |
O14746 |
TERT_HUMAN |
Brain cancer [ICD-11: 2A00] |
O14746 |
TERT_HUMAN |
Prostate cancer [ICD-11: 2C82] |
O14746 |
TERT_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06746 |
DPOLB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q06124 |
PTN11_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q16665 |
HIF1A_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q16665 |
HIF1A_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
Q16665 |
HIF1A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
P04637 |
P53_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P04637 |
P53_HUMAN |
Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E] |
P04637 |
P53_HUMAN |
Metastatic liver/bile duct neoplasm [ICD-11: 2D80] |
P04637 |
P53_HUMAN |
Transplant rejection [ICD-11: NE84] |
P04637 |
P53_HUMAN |
Ovarian dysfunction [ICD-11: 5A80] |
P04637 |
P53_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 |
P53_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P04637 |
P53_HUMAN |
Brain cancer [ICD-11: 2A00] |
P04637 |
P53_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P04637 |
P53_HUMAN |
Esophageal cancer [ICD-11: 2B70] |
P04637 |
P53_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P04637 |
P53_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P04637 |
P53_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P04637 |
P53_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P04637 |
P53_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P04637 |
P53_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 |
P53_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P04637 |
P53_HUMAN |
Cervical cancer [ICD-11: 2C77] |
P04637 |
P53_HUMAN |
Endometrial cancer [ICD-11: 2C76] |
P04637 |
P53_HUMAN |
Fallopian tube cancer [ICD-11: 2C74] |
P04637 |
P53_HUMAN |
Liposarcoma [ICD-11: 2B59] |
P04637 |
P53_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P04637 |
P53_HUMAN |
Peritoneal cancer [ICD-11: 2C51] |
P04637 |
P53_HUMAN |
Toxicity [ICD-11: N.A.] |
P04637 |
P53_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 |
P53_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 |
P53_HUMAN |
Kidney failure [ICD-11: GB60-GB6Z] |
P04637 |
P53_HUMAN |
Hearing disorder [ICD-11: AB50-AB57] |
Q99685 |
MGLL_HUMAN |
General pain disorder [ICD-11: 8E43] |
Q99685 |
MGLL_HUMAN |
Tic disorder [ICD-11: 8A05] |
Q06609 |
RAD51_HUMAN |
B-cell lymphoma [ICD-11: 2A86] |
Q06609 |
RAD51_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |